FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898030699> ?p ?o ?g. }

• W2898030699 endingPage "2395" @default.
• W2898030699 startingPage "2382" @default.
• W2898030699 abstract "Objective— Vascular calcification is a major risk factor for rupture of atherosclerotic plaques. High expression of BMP2 (bone morphogenetic protein 2) in lesions suggests its importance in vascular calcification during atherosclerosis. Teniposide is a Topo II (DNA topoisomerase II) inhibitor and is used for cancer treatment. Previously, we reported that teniposide activated macrophage ABCA1 (ATP-binding cassette transporter A1) expression and free cholesterol efflux indicating Topo II inhibitors may demonstrate antiatherogenic properties. Herein, we investigated the effects of teniposide on the development of atherosclerosis and vascular calcification in apoE −/− (apoE deficient) mice. Approach and Results— apoE −/− mice were fed high-fat diet containing teniposide for 16 weeks, or prefed high-fat diet for 12 weeks followed by high-fat diet containing teniposide for 4 weeks. Atherosclerosis and vascular calcification were determined. Human aortic smooth muscle cells were used to determine the mechanisms for teniposide-inhibited vascular calcification. Teniposide reduced atherosclerotic lesions. It also substantially reduced vascular calcification without affecting bone structure. Mechanistically, teniposide reduced vascular calcification by inactivating BMP2/(pi-Smad1/5/8 [mothers against decapentaplegic homolog 1, 5, and 8])/RUNX2 (runt-related transcription factor 2) axis in a p53-dependent manner. Furthermore, activated miR-203-3p by teniposide functioned as a link between activated p53 expression and inhibited BMP2 expression in inhibition of calcification. Conclusions— Our study demonstrates that teniposide reduces vascular calcification by regulating p53-(miR-203-3p)-BMP2 signaling pathway, which contributes to the antiatherogenic properties of Topo II inhibitors." @default.
• W2898030699 created "2018-10-26" @default.
• W2898030699 creator A5002771707 @default.
• W2898030699 creator A5005205790 @default.
• W2898030699 creator A5006799945 @default.
• W2898030699 creator A5017294775 @default.
• W2898030699 creator A5028875731 @default.
• W2898030699 creator A5033904021 @default.
• W2898030699 creator A5044788727 @default.
• W2898030699 creator A5052588320 @default.
• W2898030699 creator A5059838901 @default.
• W2898030699 creator A5060454242 @default.
• W2898030699 creator A5074266536 @default.
• W2898030699 creator A5075518661 @default.
• W2898030699 creator A5079730676 @default.
• W2898030699 creator A5084926415 @default.
• W2898030699 creator A5088229898 @default.
• W2898030699 date "2018-10-01" @default.
• W2898030699 modified "2023-09-26" @default.
• W2898030699 title "Inhibition of Vascular Calcification" @default.
• W2898030699 cites W1606722513 @default.
• W2898030699 cites W1968828441 @default.
• W2898030699 cites W1994596418 @default.
• W2898030699 cites W1997812904 @default.
• W2898030699 cites W2009801812 @default.
• W2898030699 cites W2011966598 @default.
• W2898030699 cites W2013714561 @default.
• W2898030699 cites W2013721931 @default.
• W2898030699 cites W2018494697 @default.
• W2898030699 cites W2034248800 @default.
• W2898030699 cites W2034953297 @default.
• W2898030699 cites W2041051519 @default.
• W2898030699 cites W2045932944 @default.
• W2898030699 cites W2078097381 @default.
• W2898030699 cites W2080961942 @default.
• W2898030699 cites W2081220000 @default.
• W2898030699 cites W2092661616 @default.
• W2898030699 cites W2094212146 @default.
• W2898030699 cites W2095771807 @default.
• W2898030699 cites W2096268559 @default.
• W2898030699 cites W2112046721 @default.
• W2898030699 cites W2114439420 @default.
• W2898030699 cites W2120439472 @default.
• W2898030699 cites W2124624490 @default.
• W2898030699 cites W2131567644 @default.
• W2898030699 cites W2131985274 @default.
• W2898030699 cites W2134857656 @default.
• W2898030699 cites W2137079147 @default.
• W2898030699 cites W2147834547 @default.
• W2898030699 cites W2150762378 @default.
• W2898030699 cites W2155088148 @default.
• W2898030699 cites W2155185827 @default.
• W2898030699 cites W2156184287 @default.
• W2898030699 cites W2162764839 @default.
• W2898030699 cites W2327145068 @default.
• W2898030699 cites W2544377937 @default.
• W2898030699 cites W2550875158 @default.
• W2898030699 cites W2737249697 @default.
• W2898030699 cites W4244095134 @default.
• W2898030699 cites W4296816736 @default.
• W2898030699 doi "https://doi.org/10.1161/atvbaha.118.311546" @default.
• W2898030699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30354214" @default.
• W2898030699 hasPublicationYear "2018" @default.
• W2898030699 type Work @default.
• W2898030699 sameAs 2898030699 @default.
• W2898030699 citedByCount "36" @default.
• W2898030699 countsByYear W28980306992018 @default.
• W2898030699 countsByYear W28980306992019 @default.
• W2898030699 countsByYear W28980306992020 @default.
• W2898030699 countsByYear W28980306992021 @default.
• W2898030699 countsByYear W28980306992022 @default.
• W2898030699 countsByYear W28980306992023 @default.
• W2898030699 crossrefType "journal-article" @default.
• W2898030699 hasAuthorship W2898030699A5002771707 @default.
• W2898030699 hasAuthorship W2898030699A5005205790 @default.
• W2898030699 hasAuthorship W2898030699A5006799945 @default.
• W2898030699 hasAuthorship W2898030699A5017294775 @default.
• W2898030699 hasAuthorship W2898030699A5028875731 @default.
• W2898030699 hasAuthorship W2898030699A5033904021 @default.
• W2898030699 hasAuthorship W2898030699A5044788727 @default.
• W2898030699 hasAuthorship W2898030699A5052588320 @default.
• W2898030699 hasAuthorship W2898030699A5059838901 @default.
• W2898030699 hasAuthorship W2898030699A5060454242 @default.
• W2898030699 hasAuthorship W2898030699A5074266536 @default.
• W2898030699 hasAuthorship W2898030699A5075518661 @default.
• W2898030699 hasAuthorship W2898030699A5079730676 @default.
• W2898030699 hasAuthorship W2898030699A5084926415 @default.
• W2898030699 hasAuthorship W2898030699A5088229898 @default.
• W2898030699 hasBestOaLocation W28980306991 @default.
• W2898030699 hasConcept C126322002 @default.
• W2898030699 hasConcept C134018914 @default.
• W2898030699 hasConcept C160160445 @default.
• W2898030699 hasConcept C181199279 @default.
• W2898030699 hasConcept C185592680 @default.
• W2898030699 hasConcept C202751555 @default.
• W2898030699 hasConcept C2776363554 @default.
• W2898030699 hasConcept C2776694085 @default.
• W2898030699 hasConcept C2778119113 @default.

• next